What Ebola Means for Investors
Shares of Tekmira Pharmaceuticals (TKMR) have been surging as the company is now in clinical trials to create a drug for the virus. The company has been given approval by the FDA to give its TKM-Ebola drug to subjects “with confirmed or suspected Ebola virus infections.”
The recent U.S. case of Ebola in the U.S. also now has pharmaceutical companies racing to create a vaccine for the virus.
The companies involved in the treatment or vaccination of the virus range from small biotech companies to pharma giants like GlaxoSmithKline (GSK).
Mutual Funds to Watch
|Ticker||Mutual Fund||Exposure||% of Shares Owned|
|FBDIX||Franklin Biotechnology Discovery A||Tekmira Pharmaceuticals (TKMR)||3.15%|
|SHSAX||BlackRock Health Sciences Opps Inv A||Tekmira Pharmaceuticals (TKMR)||1.53%|
|FBIOX||Fidelity Select Biotechnology Portfolio||NewLink Genetics Corp (NLNK)||5.93%|
The Bottom Line
There are several mutual funds that offer specific exposure to these industries including the funds listed above.
Sign up for Advisor Access
Receive email updates about best performers, news, CE accredited webcasts and more.
Let’s face it, the words we use everyday matter! Our content for this...